Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy

OBJECTIVE: To evaluate the radiological tumor response patterns and compare the response assessments based on immune-based therapeutics Response Evaluation Criteria in Solid Tumors (iRECIST) and RECIST 1.1 in metastatic clear-cell renal cell carcinoma (mccRCC) patients treated with programmed cell d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bingjie, Shin, Ji Hoon, Li, Hailiang, Chen, Yanqiong, Guo, Yuan, Wang, Meiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2021
Materias:
Genitourinary Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909853/
https://www.ncbi.nlm.nih.gov/pubmed/33289356
http://dx.doi.org/10.3348/kjr.2020.0404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909853/
https://www.ncbi.nlm.nih.gov/pubmed/33289356
http://dx.doi.org/10.3348/kjr.2020.0404

Ejemplares similares